Antimicrobial Susceptibility Patterns of Contemporary Pathogens from Uncomplicated Urinary Tract Infections Isolated in a Multicenter Italian Survey: Possible Impact on Guidelines

References

• Nicolle LE. Empirical treatment of acute cystitis in women. Internat J Antimicrob Chemother 2003; 221–226.
   Google Scholar
• Fihn SD. Acute uncomplicated urinary tract infections in women. N Engl J Med 2003; 349: 259–266.
   PubMed Web of Science ®Google Scholar
• Finer G, Landau D. Pathogenesis of urinary tract infec-tions with normal female anatomy. Lancet 2004; 4: 631–635.
   PubMed Web of Science ®Google Scholar
• Bishop MC. Uncomplicated urinary tract infections. Eur Assoc Urol 2004; 2: 143–150.
   Google Scholar
• Warren JW, Abrutyn E, Hebel JR, et al. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cysti-tis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis 1999; 29 (4): 745–758.
   PubMed Web of Science ®Google Scholar
• Naber KG, Bergman B, Bishop MC, et al. EAU guide-lines for the management of urinary and male genital tract infections. Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU); Eur Urol 2001; 40: 576–588.
   Google Scholar
• Odenholt I, Bylander-Groth A, Frimon-Moller N, Rokstan KS, Molstad S. Difference in antibiotic prescribing patterns between general practitioners in Scandinavia: A ques-tionnaire study. Scand J Infect Dis 2002; 34, 602–609.
   PubMed Web of Science ®Google Scholar
• Concia E, Mazzei T, Schito GC et al. Orientamenti ter-apeutici per il trattamento delle infezioni delle vie urinarie in Medicina interna, Giornale Italiano di Medicina Interna 2 2003; Suppl. 3, 1-48.
   Google Scholar
• Cersosimo L, Catanzaro F, Imparato E et al. Raccomandazioni per il trattamento delle infezioni delle vie urinarie non complicate nell'adulto. Farmaci e Terapia 2004; XXI: 1-15.
   Google Scholar
• Gupta K. Addressing Antibiotic Resistance. Dis Monitor 2003; 43: 99–110.
   Web of Science ®Google Scholar
• Kahlmeter G. An international survey of the antimicro-bial susceptibility of pathogens of uncomplicated urinary tract infections: the ECO-SENS Project. J Antimicrob Chemother 2003; 51: 69–76.
   PubMed Web of Science ®Google Scholar
• National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that grow Aerobically - 4th Edition: Approved Standard 4th Edition M7-A5 (2002) and M100-512 (2004). Wayne, PA, NCCLS.
   Google Scholar
• Marchese A, Gualco L, Debbia EA, Schito GC and Schito AM. In vitro activity of fosfomycin against Gram-nega-tive urinary pathogens and biological cost of fosfomycin resis-tance. Int J Antimicrob Agents 2003; 22 (Suppl 2): 53–59.
   PubMed Web of Science ®Google Scholar
• Tempera G, Mirabile M, Mangiafico A, Caccamo M, Bonfiglio G. Fosfomycin tromethamine in uncomplicated uri-nary tract infections: an epidemiological survey J Chemother 2004; 16: 88–89.
   Google Scholar
• Stamm WE, Norrby SR. Urinary tract infections: dis-ease panorama and challenges. J Infect Dis 2001; 183 (Suppl 1): 1–4.
   PubMed Web of Science ®Google Scholar
• Nicoletti G, Validazione in vitro dell'attivita antibatteri-ca di prulifloxacina su uropatogeni di recente isolamento. 32° Congresso Nazionale di Microbiologia, Milano, 2004.
   Google Scholar
• Bonfiglio G, Mattina R, Cammarata E, Tempera G, et al., Fosfomycin tromethamine in uncomplicated urinary tract infections: a clinical study. Chemotherapy, 2004, in press.
   Google Scholar
• Raz R, Chazan B, Kennes Y, et al. Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geo-graphical area with a high prevalence of TMP-SMX-resistant uropathogens. Clin Infect Dis 2002; 34: 1165–1169.
   Google Scholar
• Hooton TM. Fluoroquinolones and resistance in the treatment of uncomplicated urinary tract infection. Int J Antimicrob Agents 2003; 22 (Suppl 2): 65–72.
   PubMed Web of Science ®Google Scholar
• Naber KG Survey on antibiotic usage in the treatment of urinary tract infections. J Antimicrob Chemother 2000; 46 (Suppl. A): 49-52.
   Google Scholar
• Schito GC, Marchese A, Elkharrat D, Farrell DJ; PRO-TEKT Study Group. Comparative activity of telithromycin against macrolide-resistant isolates of Streptococcus pneumo-niae: results of two years of the PROTEKT surveillance study. J Chemother 2004; 16: 13–22.
   PubMed Web of Science ®Google Scholar
• Magee JT, Pritchard EL, Fitzgerald KA et al. Antibiotic prescribing and antibiotic resistance in community practice: retrospective study. Br Med J 1999; 319: 1239–40.
   PubMed Web of Science ®Google Scholar
• Kahlmeter G. Prevalence and antimicrobial susceptibili-ty of pathogens in uncomplicated cystitis in Europe. The ECO-SENS study. Int J Antimicrob Agents 2003; 22 (Suppl 2): 49–52.
   PubMed Web of Science ®Google Scholar
• Karlowsky JA, Kelly II, Thornsberry C, et al. Trends in antimicrobial resistance among urinary tract infection iso-lates of Escherichia coli from female outpatients in the United States. Antimicrob Agents Chemother 2002; 46 (8): 2540–2545.
   PubMed Web of Science ®Google Scholar
• Marutani T, Matsumoto T. Bacterial resistance to antimicrobial in urinary isolates. Int J Antimicrob Agents 2004; (Suppl 1): 28-31.
   Google Scholar
• Kiffer CRV, Mendes C, Kuti JL, et al. Pharmacodynamic comparison of antimicrobials against noso-comial isolates of E. coli, K. pneumoniae, A. baumannii and P. aeruginosa from the MYSTIC surveillance program: the OPTAMA Program, South America 2002. Diagn Microb Infect Dis 2004; 49: 109–16.
   Google Scholar
• Sheng WH, Chen YC, Wang JT, et al. Emerging fluo-roquinolone-resistance for common clinically important gra-negative bacteria in Taiwan. Diagn Microb Infect Dis 2002; 43: 141–47.
   PubMed Web of Science ®Google Scholar
• Wang M, Tran JH, Jacoby GA, et al. Plasmid-mediated quinolone resistance in clinical isolates of E. coli from Shangai, China. Antimicrob Agents Chemother 2003; 4: 2242–2248.
   Web of Science ®Google Scholar
• Lee SJ, Lee SD, Cho IR et al. Antimicrobial suscepti-bility of uropathogens causing acute uncomplicated cystitis in female outpatients in South Korea: multicentre study in 2002. Int J Antimicrob Agents 2004; 24 (Suppl 1): 61–64.
   Web of Science ®Google Scholar
• Aguiar JM, Chacon J, Canton R, Baquero F. The emergence of highly fluoroquinolone-resistant E. coli in com-munity-acquired UTI. J Antimicrob Chemother 1992; 29: 349–350.
   Google Scholar
• Garau J, Xercavis M, Rodriguez-Carballeira M, et al. Emergence and dissemination of quinolone-resistant E.coli in the community. Antimicrob Agents Chemother 1999; 43: 2736–2741.
   PubMed Web of Science ®Google Scholar
• Chomarat M. Resistance of bacteria in urinary tract infections. Int J Antimicrob Agents 2000; 16: 483-487. Kahlmeter G, Manday P, Cars O. Non-hospital antimi-crobial usage and resistance in community-acquired E.coli uri-nary tract infection. J Antimicrob Chemother 2003; 52: 1005–1010.
   Web of Science ®Google Scholar
• Schaeffer AJ. The Expanding role of fluoroquinolones. Dis Mon 2003; 49: 129–147.
   PubMed Web of Science ®Google Scholar
• Johnson AP Veterinary use of antimicrobial agents and problems of resistance in human bacterial infections. J Antimicrob Chemother 1997; 39: 285–286.
   Google Scholar
• Piddock LJV, Fluoroquinolone resistance. Br Med J 1998; 316: 1029–1030.
   Google Scholar
• Lobel B. Short term therapy for uncomplicated urinary tract infection today. Clinical outcome upholds the theory. Intern J Antimicrob Agents 2003; 22 (Suppl 2); 85-87.
   Google Scholar
• Schito GC. Why Fosfomycin trometamol as first line therapy for uncomplicated UTI. Int J Antimicrob Agents 2003; 22 (Suppl 2): 79–83.
   PubMed Web of Science ®Google Scholar
• Arca P, Reguerra G, Hardisson C. Plasmid-encoded fosfomycin resistance in bacteria isolated from the urinary tract in a multicentre survey. J Antimicrob Chemother 1997; 40: 393–399.
   PubMed Web of Science ®Google Scholar
• Li Pira G, Pruzzo C, Schito GC. Monuril and modifica-tion of pathogenicity traits in resistant microorganisms. Eur Urol 1987; 13: 92–97.
   PubMed Web of Science ®Google Scholar
• Mavromanolakis E, Maraki S, Samonis G, Tselentis Y, Cranidis A. Effect of norfloxacin, trimethoprim-sulfamethoxa-zole and nitrofurantoin on fecal flora of women with recurrent urinary tract infections. J Chemother 1997; 9: 203–7.
   PubMed Web of Science ®Google Scholar
• Nilsson Al, Berg OG, Aspevall O, et al. Biological cost and mechanisms of fosfomycin resistance in E.coli. Antimicrob Agents Chemother 2003; 47: 2850-2858.
   Google Scholar
• Ungheri D, Albini E, Belluco G. In vitro susceptibility of quinolone-resistant clinical isolates of Escherichia coli to fos-fomycin trometamol. J Chemother 2002; 14: 237–240.
   PubMed Web of Science ®Google Scholar
• Kumon H. Management of biofilm infections in the uri-nary tract. World J Surg 2000; 10: 1193–1196.
   Web of Science ®Google Scholar
• Morikawa K, Nonaka M, Toni I, Morikawa S. Modulatory effect of fosfomycin on acute inflammation in the air pouch model. Int J Antimicrob Agents 2003; 21: 334–339.
   PubMed Web of Science ®Google Scholar